glp 1 drugs and kidney function GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog GLP-1 RAs, Other Agents, Underused

Description

Besides the complex pharmacological interplay between the GIP receptor targeting ligands and the receptor addressed above, another aspect of GIP biology is the tissue-specific actions, which might affect the clinical results of GIP targeting treatments

(3) RCTs reporting both the body weight changes from baseline in the process of treatment and the body weight changes after treatment discontinuation in the follow-up study

Other GLP-1 drugs are completing trials for MASH and may be approved for it soon

Berberine may affect gut bacteria and digestion to increase peptides associated with appetite (including GLP-1), and regulate genes and blood sugar production from the liver

37 Additionally, these agents reduce the levels of proinflammatory adipokines and the expression of inflammatory genes, which can improve overall metabolic health